KRAS mutation and primary tumor location do not affect efficacy of bevacizumab-containing chemotherapy in stagae IV colorectal cancer patients

This study aims to investigate the efficacy of bevacizumab-combined chemotherapy (BCC) in Chinese stage IV colorectal cancer (CRC), and analyze the relationship between clinicopathological features with survival. Patients with stage IV CRC treated with BCC were analyzed retrospectively. 217 metastat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Sun, De-cong, Shi, Yan, Wang, Yan-rong, Lv, Yao, Yan, Huan, Mao, Hui, Wang, Zhi-kuan, Wu, Zhi-yong, Shi, Wei-wei, Dai, Guang-hai
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5662591/
https://ncbi.nlm.nih.gov/pubmed/29085005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-14669-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados